1. Clinical, imaging and pathology factors related to residual axillary disease after neoadjuvant treatment. (October 2020) Authors: Vernet-Tomas, M.; Perera, S.; Castellà, J.; Fabregó, B.; Argudo, N.; Jiménez, M.; Segura, M.; Alcantara, R.; Pitarch, M.; Arenas, N.; Plancarte, F.; Vázquez, I.; Comerma, L.; Nicolau, P. Journal: European journal of cancer Issue: Volume 138(2020)Supplement 1 Page Start: S34 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. MRI accuracy in each immunophenotype to evaluate axillary tumour load after neoadjuvant treatment. (October 2020) Authors: Vernet-Tomas, M.; Perera, S.; Castellà, J.; Fabregó, B.; Argudo, N.; Jiménez, M.; Segura, M.; Alcantara, R.; Pitarch, M.; Arenas, N.; Plancarte, F.; Vázquez, I.; Comerma, L.; Nicolau, P. Journal: European journal of cancer Issue: Volume 138(2020)Supplement 1 Page Start: S88 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. P53 and axillary tumor burden in breast cancer. (October 2020) Authors: Nicolau, P.; Argudo, N.; Jimenez, M.; Segura, M.; Maso, P.; Vazquez, I.; Comerma, L.; Servitja, S.; Martinez, M.; Martos, T.; Casadevall, D.; Alcantara, R.; Plancarte, F.; Pitarch, M.; Arenas, N.; Sanz, X.; Rodriguez, N.; Algara, M.; Vernet-Tomás, M. Journal: European journal of cancer Issue: Volume 138(2020)Supplement 1 Page Start: S35 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Patient-assisted versus standard compression in mammography screening: A randomized trial. (November 2022) Authors: Louro, J.; Posso, M.; Perez-Leon, D.; Ejarque, B.; Arranz, M.; Arenas, N.; Román, M.; Alcántara, R.; Castells, X. Journal: European journal of cancer Issue: Volume 175(2022)Supplement 1 Page Start: S32 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Sentinel node mapping in patients with biopsy-proven metastatic axillary lymph nodes and upfront surgery: preliminary results of the Multimodal Targeted Axillary Surgery (MUTAS) trial. (November 2022) Authors: Masó, P.; Jiménez, M.; Vidal-Sicart, S.; Alcantara, R.; Argudo, N.; Nicolau, P.; De Miguel, M.; Martínez, A.; Aguilar, Y.; Rubio, L.; Valhondo, R.; Arenas, N.; Pitarch, M.; Vázquez, I.; Comerma, L.; Sanz, J.; Algara, M.; Noguera, A.; Vernet-Tomas, M. Journal: European journal of cancer Issue: Volume 175(2022)Supplement 1 Page Start: S16 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗